379 related articles for article (PubMed ID: 8913541)
21. New angiotensin-II blocker.
Lilley LL; Guanci R
Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
[No Abstract] [Full Text] [Related]
22. Angiotensin II antagonism: a new avenue of hypertension management.
Gavras H
Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
[TBL] [Abstract][Full Text] [Related]
23. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
24. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
25. [Angiotensin receptor antagonists. A new class of antihypertensive agents].
Mann J
Dtsch Med Wochenschr; 1996 Apr; 121(17):568-71. PubMed ID: 8620827
[No Abstract] [Full Text] [Related]
26. Clinical experience with angiotensin II receptor antagonists.
Lee RJ; Brunner HR
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
[TBL] [Abstract][Full Text] [Related]
27. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells.
Weerackody RP; Chatterjee PK; Mistry SK; McLaren J; Hawksworth GM; McLay JS
Exp Nephrol; 1997; 5(3):253-62. PubMed ID: 9208286
[TBL] [Abstract][Full Text] [Related]
28. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
Pichler M; Klein W; Huber K; Pachinger O
Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
[TBL] [Abstract][Full Text] [Related]
29. The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects.
Braszko J
Acta Neurobiol Exp (Wars); 1996; 56(1):49-54. PubMed ID: 8787210
[TBL] [Abstract][Full Text] [Related]
30. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
Krasnikova TL
Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
[No Abstract] [Full Text] [Related]
31. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
le Tran Y; Forster C
Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
[TBL] [Abstract][Full Text] [Related]
32. Effects of Losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
Suzuki Y; Matsumura Y; Egi Y; Morimoto S
J Pharmacol Exp Ther; 1992 Dec; 263(3):956-63. PubMed ID: 1469652
[TBL] [Abstract][Full Text] [Related]
33. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
van Zwieten PA; Lie KI
Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1529-33. PubMed ID: 7675129
[No Abstract] [Full Text] [Related]
34. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
35. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
Raiden S; Giordano M; Andonegui G; Trevani AS; López DH; Nahmod V; Geffner JR
J Pharmacol Exp Ther; 1997 May; 281(2):624-8. PubMed ID: 9152365
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
[TBL] [Abstract][Full Text] [Related]
37. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
Mallion JM; Goldberg AI
Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546
[TBL] [Abstract][Full Text] [Related]
38. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
Zimlichman R
Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
[No Abstract] [Full Text] [Related]
39. The role of angiotensin II receptors and their antagonists in hypertension.
van Zwieten PA
Ann Ital Med Int; 2000; 15(1):85-91. PubMed ID: 10842896
[TBL] [Abstract][Full Text] [Related]
40. [Angiotensin II receptor antagonists].
Bornkessel B
Med Monatsschr Pharm; 1995 Jun; 18(6):148-51. PubMed ID: 7609710
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
